Orthopediatrics (KIDS) Common Equity (2015 - 2026)

Orthopediatrics has reported Common Equity for 12 years, with the latest figure at $338.7 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity fell 2.43% year-over-year to $338.7 million; the trailing twelve-month figure through Mar 2026 stood at $338.7 million (down 2.43% YoY), and the FY2025 full-year result was $346.6 million, down 2.25% from the prior year.
• Common Equity for Q1 2026 stood at $338.7 million, down from $346.6 million in the prior quarter.
• The five-year high for Common Equity was $383.3 million in Q3 2022, with the low at $215.0 million in Q1 2022.
• Average Common Equity over 5 years is $347.9 million, with a median of $370.6 million recorded in 2024.
• Year-over-year, Common Equity soared 73.52% in 2023 and decreased 6.32% in 2025.
• Tracing KIDS's Common Equity over 5 years: stood at $378.6 million in 2022, then declined by 0.43% to $377.0 million in 2023, then declined by 5.96% to $354.6 million in 2024, then slipped by 2.25% to $346.6 million in 2025, then fell by 2.27% to $338.7 million in 2026.
• The last three Common Equity figures came in at $338.7 million (Q1 2026), $346.6 million (Q4 2025), and $349.3 million (Q3 2025), per Business Quant data.

Peer Comparison